Navigation Links
Endologix Reports 30% Third Quarter 2010 Revenue Growth
Date:10/27/2010

IRVINE, Calif., Oct. 27 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, today announced financial results for the three and nine months ended September 30, 2010.

John McDermott, Endologix President and Chief Executive Officer, said, "Our strong results were driven by the effectiveness of our sales team and the successful roll out of the new Powerlink sizes and PowerFit aortic extensions during the third quarter.  We received very positive physician feedback on the new products during their limited release and accelerated the full market release into September.  The addition of these new products allows our U.S. sales team to gain additional procedures and provides physicians the opportunity to offer the unique benefits of anatomical fixation to more patients."

Mr. McDermott added, "We also continue to progress on all fronts with our new product initiatives.  Enrollment in our PEVAR (Percutaneous Endovascular Aneurysm Repair) clinical trial is on track to be completed in 2011, positioning us to be the only company with a percutaneous indication in 2012.  We also recently announced a development and exclusive license agreement with Evasc Medical Systems Corp. that secures core technology being used in our Ventana fenestrated stent graft.  Today, we announced that we have signed a definitive agreement to acquire Nellix, Inc., a privately-held medical device company which provides an innovative, next-generation product platform that could further separate Endologix from the competition and position the company to become a market leader in minimally invasive devices to treat aortic disorders."

Financial ResultsTotal revenue in the third quarter of 2010 was $17.9 million, a 30% increase from $13.8 million in the third quarter of 2009 and a 14% sequential increase. &#
'/>"/>

SOURCE Endologix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Endologix Comments on Alleged Patent Infringement
2. Endologix Responds to Alleged Patent Infringement
3. Endologix to Report Third Quarter 2009 Financial Results on October 27, 2009
4. Endologix Reports 47% Third Quarter 2009 Revenue Growth
5. Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement
6. Endologix Enters Development Agreement and Exclusive License for Balloon Expandable Stent Technology
7. Endologix Receives CE Mark Approval for Expanded Line of Powerlink Products and PowerFit Aortic Extensions
8. Endologix to Report Third Quarter 2010 Financial Results on October 27, 2010
9. Endologix Announces Publication of Clinical Trial Results Supporting Anatomical Fixation with a Suprarenal Aortic Extension
10. Endologix to Present at Oppenheimer 21st Annual Healthcare Conference
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... Aug. 27, 2015  Zimmer Biomet Holdings, Inc. (NYSE ... announced that it will be participating in the Goldman ... Goldman Sachs offices in London ... Company Founded in 1927 and headquartered in ... leader in musculoskeletal healthcare.  We design, manufacture and market ...
(Date:8/27/2015)... 27, 2015 WuXi PharmaTech (Cayman) Inc. (NYSE: ... platform company serving the pharmaceutical, biotechnology, and ... development and manufacturing subsidiary Shanghai SynTheAll Pharmaceutical ... from the Japan PMDA for the manufacture ... commercial drug in July. STA is now ...
(Date:8/27/2015)... -- Symbiomix today announced the completion of patient enrollment in ... of SYM-1219, which is a single-dose, oral product candidate ... year Symbiomix announced positive results from the first pivotal ... pivotal trial by the end of 2015, which would ... U.S. Food and Drug Administration (FDA) in mid-2016. ...
Breaking Medicine Technology:WuXi PharmaTech's STA Subsidiary Receives First Approval from Japanese Regulatory Authorities 2Symbiomix Therapeutics Completes Enrollment in Second Pivotal Trial of SYM-1219 for Bacterial Vaginosis, and Receives FDA Fast Track Designation 2Symbiomix Therapeutics Completes Enrollment in Second Pivotal Trial of SYM-1219 for Bacterial Vaginosis, and Receives FDA Fast Track Designation 3Symbiomix Therapeutics Completes Enrollment in Second Pivotal Trial of SYM-1219 for Bacterial Vaginosis, and Receives FDA Fast Track Designation 4
(Date:8/27/2015)... ... August 27, 2015 , ... ... for quantitative PCR (qPCR) in the last decade. New features such ... operating costs. On the flipside, where do lab managers, technicians, and researchers find ...
(Date:8/27/2015)... ... ... According to an article published August 19 on Healio, The ... doctors and patients on the best practices for type 2 diabetes care. The article ... new version is taking into account nearly a decade of recent research data. While ...
(Date:8/27/2015)... ... August 27, 2015 , ... Thriveology Founders, Dr. Carly Letzt ... at The Amazing Aging Expo in Denver, Colorado on Saturday, August 29, 2015 at ... featured in media outlets as health authorities, and will present a two part seminar ...
(Date:8/27/2015)... ... August 27, 2015 , ... In mid-May, ... marijuana industry with the launch of its Doobster platform, a HIPAA-compliant mobile application ... products from their smart phones and tablets. Well, Doobster, “The App That ...
(Date:8/27/2015)... , ... August 27, 2015 , ... ... years after Hurricane Katrina slammed into the Gulf Coast, killing more than 1,800 ... $100 billion, according to a Georgia State University study. , While most people ...
Breaking Medicine News(10 mins):Health News:Douglas Scientific® Webinar Outlines Comparisons of Varied qPCR Instruments 2Health News:Douglas Scientific® Webinar Outlines Comparisons of Varied qPCR Instruments 3Health News:Article on New Diabetic Care Guidelines Shines Brightly on Weight Loss Surgery, notes Beverly Hills Physicians 2Health News:Article on New Diabetic Care Guidelines Shines Brightly on Weight Loss Surgery, notes Beverly Hills Physicians 3Health News:Internationally-renowned Naturopathic Doctor and Chiropractor Team up to Reveal Secrets of Avoiding Disease 2Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 2Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 3Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 4Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 5Health News:About 10 Percent of Mothers Experienced Depression Two Years After Hurricane Katrina, New Study Shows 2
... ... ), offers men and women a more youthful look for summer with BOTOX Cosmetic and the ... ... Regenass, and her staff understand just how frustrating the signs of aging and sun damage can ...
... Scholarship Program (HPSP) Supports Students Pursuing Medical Careers with ... June 22 The U.S. Army Medical Department announced ... its Health Professions Scholarship Program (HPSP) to $1,992 per ... many medical and dental students are faced with anxiety ...
... - Bioniche Life Sciences Inc. ("Bioniche"; TSX: BNC), ... an update on its corporate activities. , In ... delays in concluding a partnering transaction related to ... Urocidin(TM), for the intravesical treatment of non-muscle-invasive bladder ...
... self-help technique called guided imagery has been steadily gaining ... insurance companies, as new research demonstrates its efficacy for ... June 22 A new self-help audio recording designed ... or other viral and bacterial illnesses was released this ...
... ... latex clear and color condoms, IBI Synergy, Inc. is looking for organizations/individuals that are interested in ... 1,000 condoms with the minimum donation being two cases. , ... Fremont, Calif. (PRWEB) June 21, 2009 -- Are you looking for a few ...
... , ... the release of a comprehensive global report on Brachytherapy market. Brachytherapy is emerging as ... billion by 2015. Primary growth drivers include rising prevalence of cancer, growing medical awareness, ... ...
Cached Medicine News:Health News:Look Great this Summer, Phoenix! BOTOX and Juvederm Offered at Beauty Open House with Dr. Heidi Regenass, June 25th 2Health News:Look Great this Summer, Phoenix! BOTOX and Juvederm Offered at Beauty Open House with Dr. Heidi Regenass, June 25th 3Health News:Look Great this Summer, Phoenix! BOTOX and Juvederm Offered at Beauty Open House with Dr. Heidi Regenass, June 25th 4Health News:U.S. Army Increases Medical and Dental School Benefits 2Health News:U.S. Army Increases Medical and Dental School Benefits 3Health News:Bioniche Provides a Corporate Update 2Health News:Cancer Patients Use New Guided Imagery CD to Help Boost Healthy Immune Functioning 2Health News:Cancer Patients Use New Guided Imagery CD to Help Boost Healthy Immune Functioning 3Health News:Premium Latex Condom Donation by IBI Synergy, Inc. Are You Looking For a Few Good Latex Condoms? 2Health News:Premium Latex Condom Donation by IBI Synergy, Inc. Are You Looking For a Few Good Latex Condoms? 3Health News:US Brachytherapy Market to Reach $1.6 Billion by 2015, According to New Report by Global Industry Analysts, Inc. 2Health News:US Brachytherapy Market to Reach $1.6 Billion by 2015, According to New Report by Global Industry Analysts, Inc. 3
... latest addition to the HemoCue glucose product range. ... combines the precision and accuracy of a laboratory ... ease of use. The new pocket size analyser ... date and time for up to 600 measurements. ...
ELISA for the detection of C. difficile toxin A in stool specimens...
... should not suffice, then electronic magnification comes into ... set today. With an electronic television reader, text, ... 70 times. A video camera shows a recorded ... monitor. The television reader has been especially developed ...
... combination of topography, auto-refraction and keratometer in ... devices. The compactness of this instrument is ... space and cost saving solution. Highly ... time and easy handling makes working with ...
Medicine Products: